#pharmaceutical-market
GLP-1 Receptor Agonist Market Projected to Reach USD 307 Billion by 2035 Driven by Expanding Metabolic Disease Burden – SNS Insider
U.S. market projected to grow from USD 27.27 billion in 2025 to USD 138.15 billion by 2035 at a 17.61% CAGR, while Europe is expected to rise from USD 16.84 billion to USD 78.24 billion over the same period, expanding at a 16.59% CAGR. U.S. market projected t…
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
LONDON, May 25, 2026 /PRNewswire/ -- The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR of 9.7% in the coming years. This growth is drive…
GLP-1 Agonists Market Outlook Report 2026-2034: New Entrants Face Barriers Due to Consolidation and Patent Protections, Yet Opportunities Lie Within Niche Areas and Emerging Markets
The GLP-1 Agonists Market offers growth opportunities due to rising diabetes cases, innovations in drug delivery, and personalized medicine. Strategic partnerships, especially in the Asia-Pacific, could capitalize on enhanced healthcare access. Challenges inc…
[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research
The pharmaceutical suppositories market size is projected to reach USD 13.4 billion by 2034 from its value of USD 9.5 billion in 2024, at a CAGR of 3.5%...
Trulicity Market Size to Reach USD 15.30 Billion by 2035 with Strong Demand for Metabolic Treatments | SNS Insider
U.S. Trulicity Market to Reach USD 4.87 Billion by 2035 Driven by Rising Diabetes Prevalence U.S. Trulicity Market to Reach USD 4.87 Billion by 2035 Driven by Rising Diabetes Prevalence